Emil D Kakkis

USPTO Granted Patents = 44 (Patent Applications = 29)

CIPO Patents = 4 (Patent Applications = 5)

EPO Patents = 14 (Patent Applications = 15)

Average Co-Inventor Count = 2.2

ph-index = 14

Forward Citations = 596(Granted Patents)

Location History:

Long Beach, CA (US) (2002)
San Rafael, CA (US) (2015 - 2022)
Novato, CA (US) (2003 - 2023)

Company Filing History:

21 out of 135

Biomarin Pharmaceutical Inc.

patents

17 out of 27

Ultragenyx Pharmaceutical Inc.

patents

4 out of 45

Kyowa Kirin Co., Ltd.

patents

4. 2 out of 11

Harbor-ucla Research and Education Institute

patents

5. 1 out of 83

Los Angeles Biomedical Research Institute at Harbor-ucla Medical Center

7. 3 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2002-2025

where 'Filed Patents' based on already Granted Patents

44 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12358976 - Methods for increasing serum concentration of phosphorous and/or 1,25-hydroxy vitamin d (2025-07-15),

2. 11771748 - Methods for treating tumor-induced osteomalacia (2023-10-03),

3. 11753369 - Creatine prodrugs, compositions and methods of use thereof (2023-09-12),

4. 11505790 - Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof (2022-11-22),

5. 11332438 - Creatine prodrugs, compositions and methods of use thereof (2022-05-17),

6. 11202822 - Methods for treating hypophosphatemic disorders (2021-12-21),

7. 11040088 - Delivery of therapeutic compounds to the brain and other tissues (2021-06-22),

8. 10889607 - Sialic acid analogs (2021-01-12),

9. 10639360 - Methods for treating hypophosphatemic disorders (2020-05-05),

10. 10457701 - Sialic acid analogs (2019-10-29),

11. 10221408 - Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof (2019-03-05),

12. 10065981 - Sialic acid analogs (2018-09-04),

13. 9993481 - Methods and compositions for the treatment of metabolic disorders (2018-06-12),

14. 9937243 - Sialylated glycoprotein compositions and uses thereof (2018-04-10),

15. 9687532 - Sialylated glycoprotein compositons and uses thereof (2017-06-27),

Title: Inventor Emil D Kakkis - Revolutionizing the Field of Medicine

Introduction: Emil D Kakkis is a renowned inventor based in Novato, California. He has made significant contributions to the field of medicine through his innovative inventions and groundbreaking research.

Latest Patents: Emil D Kakkis holds several patents in the medical field, focusing on rare diseases and genetic disorders. His patents have paved the way for new treatments and therapies that have improved the lives of countless individuals worldwide.

Career Highlights: With a background in biochemistry and genetics, Emil D Kakkis has dedicated his career to finding solutions for rare diseases that were previously untreatable. He founded a biotechnology company that specializes in developing therapies for these conditions, showcasing his entrepreneurial spirit and commitment to making a difference.

Collaborations: Throughout his career, Emil D Kakkis has collaborated with leading researchers, medical professionals, and pharmaceutical companies to further his research and bring innovative treatments to market. His collaborative efforts have resulted in groundbreaking discoveries and advancements in the field of medicine.

Conclusion: Emil D Kakkis is a visionary inventor who continues to push the boundaries of medical innovation. His passion for helping those with rare diseases and genetic disorders has led to life-changing advancements in the field, making him a respected figure in the scientific community.

This text is generated by artificial intelligence and may not be accurate.